8-K/A XBRL

FORM 8-K/A

Company: NovaBay Pharmaceuticals, Inc.
Filed: December 1, 2021
Period of Report: November 5, 2021
Accession Number: 0001437749-21-027622

View Document ↗ View on SEC.gov ↗